110276 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
IMMUNE CELL HAVING MEMBRANE-BOUND IL-21, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#2Transduction of gammadelta T cells with pseudotyped retroviral vectors
#3UNIVERSAL IMMUNE CELLS FOR CANCER IMMUNOTHERAPY
#4INHIBITORS OF NFAT AND NFKB SIGNALING FOR IMPROVING IMMUNE CELL FUNCTION
#5GENE THERAPY
#6BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS
#7ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR DELTA-LIKE LIGAND 3 (DLL3)
#8METHODS FOR GENERATING GAMMA DELTA T-CELLS AND RELATED COMPOSITIONS
#9GENETICALLY ENGINEERED IMMUNE CELLS WITH CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH MULTIPLE TRANS METABOLISM MOLECULES AND THERAPEUTIC USES THEREOF
#10ENGINEERED T CELL RECEPTOR CONSTRUCTS FOR CANCER THERAPY
#113D CELL CULTURE METHODS
#12DIFFERENTIATION INDUCER CONTAINING NUCLEUS PULPOSUS CELL MASTER REGULATOR TRANSCRIPTION FACTORS, METHOD FOR PRODUCING INDUCED NUCLEUS PULPOSUS CELLS, AND USE OF INDUCED NUCLEUS PULPOSUS CELLS
#13SYSTEMS AND METHODS FOR APPLYING MECHANICAL FORCE TO LIVING CELLS TO GENERATE A PHENOTYPIC RESPONSE
#14Pocket Engineering of HLA Alleles for Treating Autoimmunity
#15METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#16NUCLEIC ACID SYSTEM TO SPECIFICALLY REPROGRAM B AND T CELLS AND USES THEREOF
#17Methods for Generating Engineered Lymphocytes
#18FUSOSOME COMPOSITIONS AND USES THEREOF
#19METHODS OF PRODUCING AN ENVELOPED VIRUS
#20ENGINEERED REGULATORY T CELLS
#21IL15-MODIFIED CAR T CELLS FOR DUAL TARGETING
#22Method and Apparatus for Producing CAR T Cells
#23MODIFIED CASEIN PROTEINS
#24METHODS FOR MANUFACTURING ADOPTIVE CELL THERAPIES
#25COMPLEMENT FACTOR H RELATED 4-SPECIFIC ANTIBODIES AND USES THEREOF
#26MODIFIED BINDING PROTEINS AND THERAPEUTIC USES THEREOF
#27NOVEL SITES FOR SAFE GENOMIC INTEGRATION AND METHODS OF USE THEREOF
#28CD1D-RESTRICTED NKT CELLS AS A PLATFORM FOR OFF-THE-SHELF CANCER IMMUNOTHERAPY
#29SYSTEMS AND METHODS FOR VIRAL TRANSFECTION OF CELLS IN A BIOREACTOR
#30ANTI-CD90 ANTIBODIES, BINDING FRAGMENTS, AND USES THEREOF
#31COMPOSITIONS AND METHODS FOR PREVENTING T CELL EXHAUSTION
#32METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#33TRUNCATED DOMAIN IV EGFR AND USES THEREOF
#34HLA ENGINEERING METHODS AND COMPOSITIONS FOR TREATMENT OF AUTOIMMUNITY
#35SYSTEMS AND METHODS FOR UPREGULATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR (LDL-R) EXPRESSION
#36TCR CONSTANT REGION PAIRING LIBRARY
#37PROTEIN-BASED T-CELL RECEPTOR KNOCKDOWN
#38COMPOSITIONS INCLUDING KILLER INNATE-LIKE T CELLS AND USES THEREOF
#39T CELLS WITH CELL-SURFACE EXPRESSION OF ADENOSINE DEAMINASE AND USES THEREOF
#40NATURAL KILLER T-CELLS AND METHODS OF USING THE SAME
#41An Immunogenic Composition of Disease-Associated Antigens for Use in a Vaccine, Antibody Production and Immunodiagnostic Tests
#42METHOD FOR PRODUCING GENE-MODIFIED T CELL POPULATION
#43COMPOSITIONS AND METHODS FOR THERAPEUTIC DELIVERY
#44VECTORS FOR PROTEIN MANUFACTURE
#45TARGETED DEGRADATION OF ALPHA-SYNUCLEIN
#46CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES THEREOF
#47ANTI-FIBROUS CELLS, MEDICAMENT COMPRISING THE CELLS, AND METHOD FOR OBTAINING THESE CELLS
#48GENE EDITING METHODS FOR MODULATING EXPRESSION OF ID-3, AN INHIBITOR OF DNA-BINDING TRANSCRIPTION FACTORS, THEREBY AFFECTING T-CELL FUNCTION
#49von Willebrand Factor Proteins for Treating Bleeding Disorders
#50NUCLEIC ACID CONSTRUCTS FOR CO-EXPRESSION OF CHIMERIC ANTIGEN RECEPTOR AND TRANSCRIPTION FACTOR, CELLS CONTAINING AND THERAPEUTIC USE THEREOF
#51Rapid T-Cell Manufacturing
#52IRF-4 ENGINEERED T CELLS AND USES THEREOF IN TREATING CANCER
#53METHODS, KITS, AGENTS AND APPARATUSES FOR TRANSDUCTION
#54Metamorphic Biomachine For Immortality
#55RETROVIRAL TRANSDUCTION USING POLOXAMERS
#56ANTISENSE TRANSFER VECTORS AND METHODS OF USE THEREOF
#57METHODS AND MATERIALS FOR TREATING CANCER
#58TRUNCATED DOMAIN IV EGFR AND USES THEREOF
#59CHIMERIC ANTIGEN RECEPTOR WITH ENDOGENOUS PROTEIN MOLECULE REPLACING SINGLE DOMAIN ANTIBODY
#60METHODS AND COMPOSITIONS FOR PROMOTING SURVIVAL & PROLIFERATION OF ENDOTHELIAL CELLS & STIMULATING ANGIOGENESIS
#61FOLATE RECEPTOR ALPHA -TARGETING BI-SPECIFIC T CELL ENGAGERS (BiTEs) AND USES THEREOF
#62COMPOSITIONS AND METHODS FOR THERAPEUTIC OR VACCINE DELIVERY
#63METHODS AND COMPOSITIONS FOR TREATING DNMT3A DEFICIENCY-ASSOCIATED DISEASES
#64BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS
#65CELLS HAVING ABILITY TO INDUCE SKIN APPENDAGES, AND PRODUCTION METHOD THEREOF
#66T CELL RECEPTOR, AND PREPARATION METHOD AND USE THEREOF
#67COMPOSITIONS AND METHODS FOR THE PRODUCTION OF LIBRARIES
#68METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND USES THEREOF
#69VECTORS
#70METHOD FOR PURIFICATION OF GMP-GRADE RETROVIRAL VECTOR AND APPLICATION THEREOF
#71COMBINATION OF PRAME SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-STIMULATORY RECEPTORS
#72CD19-Directed Chimeric Antigen Receptor Constructs
#73LARGE SCALE CAR-T IMMUNE CELL MANUFACTURING METHOD UTILIZING LENTIVIRAL VECTOR TRANSFECTION
#74MIR200C-EPCAM AXIS REPROGRAMED IMMUNE CELLS FOR ENHANCED ANTI-TUMOR FUNCTION
#75CHIMERIC COSTIMULATORY RECEPTORS, CHEMOKINE RECEPTORS, AND THE USE OF SAME IN CELLULAR IMMUNOTHERAPIES
#76LTR TRANSPOSON COMPOSITIONS AND METHODS
#77MODIFIED TUMOR-INFILTRATING LYMPHOCYTE AND USE THEREOF
#78HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION
#79Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules
#80CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS
#81CARTILAGE-DERIVED PROGENITOR CELL LINES
#82METHODS AND AGENTS FOR MODULATING ADOPTIVE IMMUNOTHERAPY
#83EXPEDITED ADMINISTRATION OF ENGINEERED LYMPHOCYTES
#84LENTIVIRUS FOR GENERATING CELLS EXPRESSING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
#85COMPOSITIONS AND METHODS TO REDUCE THERAPEUTIC T CELL TOXICITY
#86LARGE SCALE CAR-T IMMUNE CELL MANUFACTURING METHOD UTILIZING LENTIVIRAL VECTOR TRANSFECTION
#87MIR200C-EPCAM AXIS REPROGRAMED IMMUNE CELLS FOR ENHANCED ANTI-TUMOR FUNCTION
#88ANTIGEN RECOGNIZING RECEPTORS TARGETING UPAR AND USES THEREOF
#89METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#90GLOBIN GENE THERAPY FOR TREATING HEMOGLOBINOPATHIES
#91COMPOSITIONS OF GUANYLYL CYCLASE C (GCC) ANTIGEN BINDING AGENTS AND METHODS OF USE THEREOF
#92Cell
#93CELL
#94PRAME BINDING MOLECULE
#95ENGINEERED IMMUNE CELL AND USE THEREOF
#96HLA CLASS II-RESTRICTED TCRS AGAINST THE KRAS G12>V ACTIVATING MUTATION
#97NOVEL T-CELL SPECIFICITIES AND USES THEREOF
#98Methods and compositions for transducing lymphocytes and regulating the activity thereof
#99T CELL RECEPTORS RECOGNIZING R273C OR Y220C MUTATIONS IN P53
#100Pocket Engineering of HLA Alleles for Treating Autoimmunity
#101Compositions and methods for therapeutic delivery
#102METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#103CELL LINES WITH MULTIPLE DOCKS FOR GENE INSERTION
#104HLA engineering methods and compositions for treatment of autoimmunity
#105IMPROVED SCAFFOLDS FOR MULTIPLEXED INHIBITORY RNA
#106RETROVIRAL TRANSDUCTION USING POLOXAMERS
#107MITOCHONDRIA-ENRICHED GENETICALLY ENGINEERED CELLS AND USES THEREOF
#108Methods Of HLA Engineering and Treatments For Autoimmunity
#109Immune synapse-stabilizing chimeric antigen receptor (CAR) T cell
#110Pocket Engineering of HLA Alleles for Treating Autoimmunity
#111Chimeric Antigen Receptors Comprising Interleukin-9 Receptor Signaling Domain
#112ANTI-HPV T CELL RECEPTORS AND ENGINEERED CELLS
#113PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME) T CELL RECEPTORS AND METHODS OF USE THEREOF
#114ANTI TRBC1 ANTIGEN BINDING DOMAINS
#115COMPOSITIONS AND METHODS RELATING TO MYOMAKER-INDUCED MUSCLE CELL FUSION
#116Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof
#117T-CELL MASTER CELL BANK
#118UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#119LMP-1 EXPRESSING CELLS AND METHODS OF USE THEREOF
#120METHODS AND COMPOSITIONS FOR TYPE 2 DIABETES THERAPY
#121BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS
#122Methods of Activating and Proliferating Exhausted CD8 T Cells, CD8 T Cells with Enhanced Activity Prepared by the Same, and Uses Thereof
#123CD25 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#124METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING LYMPHOCYTES TO EXPRESS POLYPEPTIDES COMPRISING THE INTRACELLULAR DOMAIN OF CD79A AND CD79B
#125POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CD38 CHIMERIC ANTIGEN RECEPTOR
#126CD79-specific chimeric antigen receptor
#127VIRUS-LIKE PARTICLE
#128VIRAL VECTOR MANUFACTURING METHODS
#129Methods, kits, agents and apparatuses for transduction
#130THERAPEUTIC T-CELLS WITH MODIFIED EXPRESSION OF T-BET, EOMES, AND c-MYB TRANSCRIPTION FACTORS
#131AUTOMATED T CELL CULTURE
#132Cartilage Regeneration Using Chondrocyte And TGF-Beta
#133ARGONAUTE PROTEINS FROM PROKARYOTES AND APPLICATIONS THEREOF
#134DIFFERENTIATION INDUCER CONTAINING NUCLEUS PULPOSUS CELL MASTER REGULATOR TRANSCRIPTION FACTORS, METHOD FOR PRODUCING INDUCED NUCLEUS PULPOSUS CELLS, AND USE OF INDUCED NUCLEUS PULPOSUS CELLS
#135T CELL RECEPTORS AND METHODS OF USE THEREOF
#136COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITING
#137Method of Selecting for Antibodies
#138METHOD FOR EXPANSION AND DIFFERENTIATION OF T LYMPHOCYTES AND NK CELLS FOR ADOPTIVE TRANSFER THERAPIES
#139EXPANSION OF NATURAL KILLER AND CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELLS
#140UNIVERSAL IMMUNE CELLS FOR CANCER IMMUNOTHERAPY
#141Anti TRBC1 antigen binding domains
#142CAR T CELL METHODS AND CONSTRUCTS
#143CD62L specific lentiviral vector particle for targeted transduction of T cell subsets
#144Compositions and Methods for Correction of Heritable Ocular Disease
#145Vectors for protein manufacture
#146Compositions and methods to treating hemoglobinopathies
#147IMMUNE CELL FUNCTION
#148METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY
#149ACCELERATED HUMAN HEMATOPOEITIC STEM CELL DIFFERENTIATION TOWARDS MATURE NATURAL KILLER CELLS WITH ENHANCED ANTIBODY-DEPENDENT CYTOTOXIC ACTIVITY
#150Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof
#151IMPROVED VECTOR SYSTEMS FOR CAS PROTEIN AND SGRNA DELIVERY, AND USES THEREFOR
#152ENGINEERED REGULATORY T CELLS
#153METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#154METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND USES THEREOF
#155COMPOSITION OF NY-ESO-1-SPECIFIC T CELL RECEPTORS RESTRICTED ON MULTIPLE MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES
#156METHODS FOR EXPANDING ANTIGEN-SPECIFIC CAR-T CELLS, COMPOSITIONS AND USES RELATED THERETO
#157METHOD FOR THE PRODUCTION OF BI-FUNCTIONAL CELLS TO TREAT NEOPLASIA
#158BRAF-SPECIFIC TCRS AND USES THEREOF
#159FUSOSOME COMPOSITIONS AND USES THEREOF
#160BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
#161FUSOSOME COMPOSITIONS AND USES THEREOF
#162Cartilage-derived mesenchymal cell lines
#163CELL
#164Human induced pluripotent stem cell lines for modeling Alzheimer's disease and usage thereof
#165Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
#166CELL
#167Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
#168Biologically relevant orthogonal cytokine/receptor pairs
#169BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS
#170TUMOR NEOANTIGEN PREDICTION PLATFORM AND APPLICATION THEREOF IN NEOANTIGEN VACCINE DEVELOPMENT SYSTEM
#171Retroviral transduction using poloxamers
#172Engineered regulatory T cells
#173IRF-4 engineered T cells and uses thereof in treating cancer
#174UNIVERSAL ANTIGEN PRESENTING CELLS AND USES THEREOF
#175Compositions and methods to treating hemoglobinopathies
#176COMPOSITION COMPRISING A GENE VECTOR THAT SELECTIVELY DEPLETES P16 POSITIVE SENESCENT CELLS
#177Von Willebrand factor proteins for treating bleeding disorders
#178CELL LABELLING, TRACKING AND RETRIEVAL
#179Reagent for differentiating somatic cells into alveolar epithelial cells, and use of said reagent
#180Protein-based T-cell receptor knockdown
#181CAR T-cells comprising transcriptional circuits
#182METHOD FOR PRODUCING CELL FLAPS
#183Nucleic acid molecules encoding chimeric antigen receptors targeting B-cell maturation antigen and uses thereof
#184Methods of using chimeric antigen receptors targeting B-cell maturation antigen and uses thereof
#185Engineered host cells and methods of use thereof
#186METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING AND EXPANDING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#187Strong insulator and uses thereof in gene delivery
#188CD1D-restricted NKT cells as a platform for off-the-shelf cancer immunotherapy
#189Identification of T-cell trafficking genes and uses thereof for increasing infiltration of T-cells into solid tumors
#190Cell line for producing adenovirus and method of preparing the same
#191Anti TRBC1 antigen binding domains
#192ANIMAL MODEL OF A MOOD DISORDER AND SCREENING METHOD
#193Methods, kits, agents and apparatuses for transduction
#194Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
#195CELL
#196Cell
#197Compositions and methods relating to myomaker-induced muscle cell fusion
#198HYBRID NUCLEIC ACID MOLECULES AND THEIR USE
#199SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS
#200Compositions and methods to treating hemoglobinopathies
#201Composition comprising a gene vector that selectively depletes P16 positive senescent cells
#202Compositions, methods, and therapeutic uses related to fusogenic protein minion
#203METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION
#204METHODS FOR INDUCING STEREOCILIA ON HAIR CELLS
#205HBV antigen specific binding molecules and fragments thereof
#206Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors
#207LMP1-expressing cells and methods of use thereof
#208Biologically relevant orthogonal cytokine/receptor pairs
#209Methods for expanding and activating γδ T cells for the treatment of cancer and related malignancies
#210Replication conditional virus that specifically kills senescent cells
#211NUCLEIC ACID CONSTRUCTS FOR PRODUCING RETROVIRAL VECTORS
#212Cell
#213Compositions and methods for correction of heritable ocular disease
#214Chimeric antigen receptors targeting B-cell maturation antigen and uses thereof
#215Fetal hemoglobin for genetic correction of sickle cell disease
#216Enhanced expression and stability regions
#217System comprising a nucleotide sequence encoding a volvox carteri light-activated ion channel protein (VCHR1)
#218Method for producing CD4-positive T cells from pluripotent stem cells
#219Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
#220T cell receptor library
#221Biologically relevant orthogonal cytokine/receptor pairs
#222Method of painting micro vesicles
#223Gene therapy vector system and prodrug genes
#224CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY
#225PD-1 immune modulating agents
#226Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor
#227NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR
#228Protein-based T-cell receptor knockdown
#229Universal immune cells for cancer immunotherapy
#230Therapeutic miRNAs for treating heart and skeletal muscle diseases
#231Retroviral transduction using poloxamers
#232Chimeric antigen receptor signalling system comprising heterodimerization domains
#233GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING ALPHA-1 ANTITRYPSIN (AAT)
#234Methods and compositions for transducing lymphocytes and regulating the activity thereof
#235CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY
#236Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof
#237Reprogramming T cells and hematopoietic cells
#238Compositions and methods to treating hemoglobinopathies
#239METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS
#240Factor involved in latent infection with herpes virus, and use thereof
#241Globin gene therapy for treating hemoglobinopathies
#242Viral Vectors for Gene Editing
#243Fetal hemoglobin for genetic correction of sickle cell disease
#244System utilizing light-activated ion channel protein (VChR1) for optical stimulation of target cells
#245Expression cassette and vector comprising Alzheimer's disease-related mutant genes and cell line transformed by means of same
#246Methods for manufacturing adoptive cell therapies
#247Stable episomes based on non-integrative lentiviral vectors
#248Method of making polyethylene glycol-modified mammalian erythropoietin in a transgenic chicken
#249Fusion protein for inducing pluripotent stem cells and application method thereof
#250Therapeutically useful molecules
#251Therapeutic miRNAs for treating heart and skeletal muscle diseases
#252Cell
#253Cell
#254RECOMBINANT VECTOR WITH STABILIZING A-LOOP
#255Post release modification of viral envelopes
#256METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS
#257Methods of improving titer in transfection-based production systems using eukaryotic cells
#258Compositions and methods relating to myomaker-induced muscle cell fusion
#259Enhanced expression and stability regions
#260Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#261Diagnostic and treatment for chronic and acute phase myeloid leukemia
#262Methods for treating parkinson's disease by optically stimulating target cells
#263Replication competent pseudo-type retrovirus vector system
#264Therapeutically useful molecules
#265Vectors for transgene expression
#266Retroviral transduction using poloxamers
#267Method for gene transfer
#268Peptides with viral infection enhancing properties and their use
#269Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
#270Targeting pseudotyped retroviral vectors
#271Factor involved in latent infection with herpesvirus, and use thereof
#272Enhanced expression and stability regions
#273Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics
#274ENHANCER FOR PROMOTER, AND USE THEREOF
#275Diagnostic and treatment for chronic and acute phase myeloid leukemia
#276Mammalian cell lines for increasing longevity and protein yield from a cell culture
#277Reprogramming T cells and hematopoietic cells
#278Mammalian cell lines for increasing longevity and protein yield from a cell culture
#279METHOD FOR INCREASING RETROVIRAL INFECTIVITY
#280Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof
#281Enhanced immune response against infections
#282Compositions and methods for identifying antigens which elicit an immune response
#283Therapeutically Useful Molecules
#284Systems, methods and compositions for optical stimulation of target cells
#285Post release modification of viral envelopes
#286Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
#287Vectors and Methods for Tissue Specific Synthesis of Protein in Eggs of Transgenic Hens
#288Mammalian cell lines for increasing longevity and protein yield from a cell culture
#289Enhanced expression and stability regions
#290Modified H2 relaxin for tumor suppression
#291Diagnosis of mood disorders by detecting latent infection with human herpesvirus-6
#292Targeting pseudotyped retroviral vectors
#293HCV-REACTIVE T CELL RECEPTORS
#294Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof
#295Method for Production of T Cell Population
#296VECTORS AND METHODS FOR TISSUE SPECIFIC SYNTHESIS OF PROTEIN IN EGGS OF TRANSGENIC HENS
#297Mammalian cell lines for increasing longevity and protein yield from cell culture
#298MOLECULAR SEQUENCE OF SWINE RETROVIRUS AND METHODS OF USE
#299TRANSGENIC AVIAN WHICH HAS FOREIGN GENE CONTAINING SEQUENCE ENCODING FELINE-DERIVED PROTEIN AND METHOD FOR PRODUCTION THEREOF
#300METHOD FOR TREATING TUMOR USING IRRADIATED TUMOR CELL EXPRESSING HUMAN HEPATITIS B SURFACE ANTIGEN AND A PHARMACEUTICAL COMPOSITION COMPRISING THE TUMOR CELL